Evidence map›Paper›PMID 41057850›Full record

SynthesisBMC nephrology2025

Lupus nephritis in Africa: a systematic review of case reports and case series.

Mohamed Jayte, Abdifitah Abdullahi Mohamed, Abdifatah Karshe, Awil Abdulkadir Abdi, Hanan Asad Hassan

Abstract readSystematic Review
In one paragraph

Synthesis in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamed JayteDepartment of Internal Medicine, Kampala International University, P.O. Box 7062, Kampala, Uganda. maxamedjeyte@gmail.com.
Abdifitah Abdullahi MohamedDepartment of Microbiology, Kampala International University, Kampala, Uganda.
Abdifatah KarsheDepartment of Internal Medicine, Kampala International University, P.O. Box 7062, Kampala, Uganda.
Awil Abdulkadir AbdiDepartment of Internal Medicine, Kampala International University, P.O. Box 7062, Kampala, Uganda.
Hanan Asad HassanDepartment of Internal Medicine, Kampala International University, P.O. Box 7062, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLupus nephritis remains a severe manifestation of systemic lupus erythematosus across African populations, where diagnostic and therapeutic challenges significantly impact patient outcomes. This systematic review examines the clinical spectrum and management realities of this condition in African settings.

methodsFollowing PRISMA guidelines, we identified seven qualifying studies after screening 662 records from major databases. The analysis included five case reports and two case series documenting confirmed lupus nephritis cases across multiple African regions. We systematically evaluated patient characteristics, diagnostic approaches, treatment regimens, and clinical outcomes using standardized quality assessment tools.

resultsSeven studies reporting 16 patients from four countries were included. The female-to-male ratio was 14:2 (7:1). Histological classifications included Class IV (5 cases), Class V (4 cases), Class VI (3 cases), and mixed IV/V (1 case), with one case diagnosed clinically. Two patients died and three progressed to end-stage renal disease requiring dialysis. Most cases occurred in young women, commonly presenting with nephrotic syndrome and hypertension. Proliferative and membranous patterns were the predominant biopsy findings. Corticosteroid-based regimens led to improvement in several patients, though outcomes varied regionally, with North African cases showing better responses than those from other regions where late presentation predicted poorer prognosis.

conclusionThese findings underscore both the clinical challenges and opportunities in managing lupus nephritis across Africa. The demonstrated variability in outcomes calls for coordinated efforts to establish context-appropriate diagnostic protocols and treatment guidelines, with particular attention to resource-limited settings. CLINICAL TRIALS: Not applicable.

Indexed as

Lupus NephritisAfricaFemaleHumansMaleAfricaAutoimmune diseaseDeveloping countriesLupus nephritisRenal outcomes

Identifiers

PMID41057850
PMCPMC12505651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.